Mapmygenome Acquires dnaPower to Expand North American DNA and Health Testing
Mapmygenome has completed its acquisition of Vancouver-based dnaPower Inc., expanding its presence in North America. This strategic move integrates dnaPower's consumer reach with Mapmygenome's global capabilities, including its CAP-accredited clinical laboratories and AI-driven multi-omics testing. The acquisition aims to create a centralized platform for DNA, microbiome, pharmacogenetic, and longevity testing, enhancing preventive healthcare offerings across Canada and the US. Both companies' CEOs highlighted the growth potential and advanced infrastructure supporting this expansion.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (77/100). Lens Score 37/100.
Outlets measured: thehindu, businessstandard, thetribune. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–78/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thetribune broke this story on 21 Oct, 11:56 am. Other outlets followed.